openPR Logo
Press release

Dermatology Diagnostic Devices and Therapeutics Market Bolstered Growth by 2025 - Valeant Pharmaceuticals International

07-20-2018 10:14 AM CET | Health & Medicine

Press release from: TMR Research

Dermatology Diagnostic Devices and Therapeutics Market

Global Dermatology Diagnostic Devices and Therapeutics Market: Snapshot

The global dermatology diagnostic devices and therapeutics market is driven by rising number of patients suffering from skin allergies, fungal infections, and skin cancer owing to pollution and changes in the environment. In 2013, a study conducted on clinical dermatology found that 25% population was suffering from skin diseases. Among them, 15% consulted general physician which shows growing awareness among these patients for treatment of skin disease. This has boosted the demand for advanced treatments and drugs. As a part of this, key players have made investments in research and development (R&Ds) of advanced drugs.

For instance, recently, in March 2017, The US Food and Drug Administration (FDA) approved Dupixent (dupilumab) injection to treat moderate-to-severe eczema found in adults. Earlier, there were very few options to treat this disease. This is a product of one of the player operating in the market – Sanofi and Regeneron Pharmaceuticals, Inc. Sanofi Genzyme, which is the business unit of Sanofi and Regeneron, will hold the market for the drug in the US. Dupixent is the first biologic medicine approved by FDA for treatment of atopic dermatitis (AD) – eczema. This drug will be applicable when the disease cannot be controlled with topical prescription therapies or in the conditions where therapies are not advisable.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1838

Dupixent is monoclonal antibody mainly designed for signaling two overactive proteins – IL-4 and IL-13 – which are majorly responsible for inflammation in an AD. It comes in the form of a pre-filled syringe which can be administrated by patients after the initial dose, it can be injected for every alternate week. Use of topical corticosteroids is not mandatory for injecting Dupixent. However, the drug is not suitable for patients who have dupilumab allergies or other ingredients present in the drug.

Currently, this drug is available in the US market. The launch of the drug is beneficial for the market to gather revenue substantially.

Global Dermatology Diagnostic Devices and Therapeutics Market: Overview

The global dermatology diagnostic devices and therapeutics market is gaining momentum due to the high prevalence of skin diseases and disorders. The trajectory of the global market will be decided by increasing pool of geriatrics, patent expirations in the offing, and the prevalence of chronic ailments. The research report points out that supportive governmental initiatives and increasing activities to raise awareness about dangerous skin disorders are expected to work in favor of the global market.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1838

Global Dermatology Diagnostic Devices and Therapeutics Market: Drivers and Trends

The growing number of geriatrics is the key growth driver for the global dermatology diagnostic devices and therapeutics market. Aging skin is more prone to various types of skin cancer, invasive melanoma, and other diseases and disorders. Thus, increasing number of aged people have augmented the demand for dermatology diagnostic devices and therapeutics for diagnosing and treating the various conditions.

Rising pollution, changing lifestyles, and increasing usage of cosmetics has also resulted in high prevalence of acne and psoriasis, which in turn has had a positive influence on the global market. Furthermore, the increasing expenditure on healthcare and the introduction of new and improved dermatology diagnostics and devices and therapeutics have led to the growth of the overall market.

Read Comprehensive Overview of Report @ https://www.tmrresearch.com/dermatology-diagnostic-devices-therapeutics-market

Global Dermatology Diagnostic Devices and Therapeutics Market: Market Potential

Several players are trying to incorporate technology used for developing diagnostic devices into smartphones and tablets to improve the rate of diagnostics. For instance, Agfa HealthCare launched its web-enabled mobile image management technology known as ICIS, which it plans to integrate into iPhones, iPads, and other mobile digital devices. Offering healthcare through smartphones is an important step in the way of medical devices are poised to evolve for the future. This is expected to provide the patient, caregivers, and physicians a chance to capture images at any point and from any location and publishing them on safely guarded EHRs.

Such initiatives are aimed towards improving diagnostics, patient engagement, and making healthcare even more reachable. Players in the global dermatology diagnostic devices and therapeutics market are expected to focus on making healthcare easy and accessible to win bigger user bases in the near future.

Global Dermatology Diagnostic Devices and Therapeutics Market: Regional Outlook

In terms of geography, the global dermatology diagnostic devices and therapeutics market is segmented into the Middle East and North Africa, Latin America, Asia Pacific, Europe, North America, and Rest of the World. Of these, North America is expected to dominate the global market due to a higher level of awareness about skin disorders and diseases in the region. The dominance of this region will be boosted by the excellent access to healthcare and supportive reimbursement policies. The well-organized healthcare sector is also projected favor the regional market’s growth in the near future.

Europe is expected to follow North America’s lead in the coming years, while Asia Pacific will be seen as an important emerging market. The huge pool of geriatrics in Asia Pacific and the ever-increasing unmet medical needs in the developing countries of the region will also make a significant contribution to the soaring revenue of the overall market.

Key Players Mentioned in the Report are:

Some of the key players operating in the global dermatology diagnostics devices and therapeutics market are Valeant Pharmaceuticals International, Inc., Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Novartis International AG, Galderma S.A., Dino-Lite Europe/IDCP B.V., Genentech, LEO Pharma A/S, Michelson Diagnostics Ltd., and others.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dermatology Diagnostic Devices and Therapeutics Market Bolstered Growth by 2025 - Valeant Pharmaceuticals International here

News-ID: 1137220 • Views: 424

More Releases from TMR Research

IoT in Manufacturing Market Present, History, Future and Forecast 2025 | IBM Cor …
Global IoT in Manufacturing Market: Snapshot The global IoT in manufacturing market is driven by an increasing need for centralized monitoring and predictive maintenance of manufacturing infrastructure. The growing demand for operational efficiency, agile production, operational control, and connected logistics will also support the growth of the IoT in manufacturing market. The global IoT in manufacturing market is highly fragmented with the presence of both large and small companies in high
Airport Retailing Market Global Industry Trends Analysis 2025 | World Duty Free …
Global Airport Retailing Market: Snapshot Airport retailing is basically the presence of many retail services of many products inside the airport for providing enhanced convenience to the people travelling. Airport retailing also delivers a broader variety of merchandizes and is a comparatively easy choice for travelers. As many retailers tend to think that airport retailing is just strategy diversification and market expansion. However, this kind of thinking is expected to lead
Incident Response Services Market Overview and Outlook 2017 to 2025 | Dell Secur …
Global Incident Response Services Market: Snapshot Incident response refers to the management and active efforts taken after an attack or a security breach has taken place. Incident response services primarily deal with an organized approach towards the incident and most service providers adhere to the core goal of managing the incident in a way that will reduce damage in terms of time and money. Incident response service providers usually incorporate plans
Telecom Cloud Billing Market Development, Application and Forecast 2025 | Ericss …
Global Telecom Cloud Billing Market: Snapshot The global telecom cloud billing market is projected to be a forward-looking breeding ground of lucrative prospects birthing from the advent of cloud computing as a mainstream IT strategy. Cloud computing is the new in telecom billing that catalyzes important modifications in traditional billing architectures. Anticipated to reshape conventional billing concepts, cloud computing enables the deliverance of highly scalable IT resources directly over the web

All 5 Releases


More Releases for Diagnostic

Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Global Dermatology Diagnostic Devices Market
https://www.qandqmarketresearch.com/report-sample/dermatology-diagnostic-devices-market-6 This report studies the global Dermatology Diagnostic Devices market status and forecast, categorizes the global Dermatology Diagnostic Devices market size value & volume by key players, type, application, and region. This report focuses on the top players in North America, Europe, AsiaPacific, South America, and Middle East & Africa. Dermatology diagnostic devices are used for treating and diagnosing skin disorders. These devices assist in early detection of skin disorders and improving
Cervical Cancer Diagnostic Tests Market
A new market research report has been recently published by Transparency Market Research, a global market intelligence firm, and made available on the company website. The research study talks about the current scenario of global cervical cancer diagnosis tests market, along with the growth prospects of the market. The research study, titled “Cervical Cancer Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,”
Diagnostic Catheters Market 2017-2021
The latest industry research report on  Diagnostic Catheters by MRC provides a thorough analysis of the global  Diagnostic Catheters market. The report scrutinizes the market by different segments including regions, applications, competitive landscape, etc. over the predicted time frame. This report provides 360 Degree perspective of the  Diagnostic Catheters industry with an all-inclusive discussion of definitions, classifications, and market players in the industry chain structure. It features qualitative and quantitative